Association of in vivo β-adrenergic receptor sensitivity with inflammatory markers in healthy subjects

Psychosomatic Medicine

Volumn 74, Issue 3, 2012, Pages 271-277

  Euteneuer, Frank ^a,b   Mills, Paul J ^a   Rief, Winfried ^b   Ziegler, Michael G ^a   Dimsdale, Joel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

C reactive protein; chronotropic 25 dose; cytokines; inflammation; isoproterenol; adrenergic receptor

Indexed keywords

BETA ADRENERGIC RECEPTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; ISOPRENALINE; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CHRONIC STRESS; CHRONOTROPISM; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; EXERCISE; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LEISURE; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR SENSITIVITY; SMOKING HABIT;

EID: 84859698978     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e318245d762     Document Type: Article

References (101)

1. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmacol Ther 1993;60:405-30.
2. Wood AJ. Physiological regulation of beta-receptors in man. Clin Exp Hypertens 1982;4:807-17. (Pubitemid 12025384)
3. Mills PJ, Dimsdale JE. The promise of adrenergic receptor studies in psychophysiologic research II: applications, limitations, and progress. Psychosom Med 1993;55:448-57. (Pubitemid 23285175)
4. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications. J Am Coll Cardiol 2009;54:1747-62.
5. Lefkowitz RJ, Rockman HA, Koch WJ. Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 2000;101:1634-7. (Pubitemid 30196619)
6. Liggett SB. Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J Clin Invest 2001;107:947-8. (Pubitemid 32323404)
7. Kardia S, Kelly R, Keddache M, Aronow B, Grabowski G, Hahn H, Case K, Wagoner L, Dorn G, Liggett SB. Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival. BMC Med Genet 2008;9:93.
8. Dhalla NS, Dixon IM, Rupp H, Barwinsky J. Experimental congestive heart failure due to myocardial infarction: sarcolemmal receptors and cation transporters. Basic Res Cardiol 1991;86:13-23.
9. Brodde OE. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 2008;22:107-25.
10. Lambert E, Lambert G. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr Hypertens Rep 2011;13:244-8.
11. Mills PJ, Dimsdale JE. The promise of receptor studies in psychophysiologic research. Psychosom Med 1988;50:555-66. (Pubitemid 19016805)
12. Dimsdale JE, Mills P, Patterson T, Ziegler M, Dillon E. Effects of chronic stress on beta-adrenergic receptors in the homeless. Psychosom Med 1994;56:290-5. (Pubitemid 24233888)
13. Mazzola-Pomietto P, Azorin J-M, Tramoni V, Jeanningros R. Relation between lymphocyte beta-adrenergic responsivity and the severity of depressive disorders. Biol Psychiatry 1994;35:920-5. (Pubitemid 24212217)
14. Mills PJ, Ziegler MG, Patterson T, Dimsdale JE, Hauger R, Irwin M, Grant I. Plasma catecholamine and lymphocyte beta 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress. Psychosom Med 1997;59:251-6. (Pubitemid 27240726)
15. Suarez EC, Shiller AD, Kuhn CM, Schanberg S, Williams RB Jr, Zimmermann EA. The relationship between hostility and beta-adrenergic receptor physiology in health young males. Psychosom Med 1997;59:481-7. (Pubitemid 27422245)
16. Von Kaenel R, Mills PJ, Ziegler MG, Dimsdale JE. Effect of beta-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002;144:68-72. (Pubitemid 34734757)
17. Yu B-H, Dimsdale JE, Mills PJ. Psychological states and lymphocyte [beta]-adrenergic receptor responsiveness. Neuropsychopharmacology 1999;21:147-52. (Pubitemid 29253845)
18. Sherwood A, Hughes JW, Kuhn C, Hinderliter AL. Hostility is related to blunted beta-adrenergic receptor responsiveness among middle-aged women. Psychosom Med 2004;66:507-13. (Pubitemid 38971244)
19. Hughes JW, Sherwood A, Blumenthal JA, Suarez EC, Hinderliter AL. Hostility, social support, and adrenergic receptor responsiveness among African-American and white men and women. Psychosom Med 2003;65:582-7. (Pubitemid 36900253)
20. Cleaveland CR, Rangno RE, Shand DG. A standardized isoproterenol sensitivity test: the effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med 1972;130:47-52.
21. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12. (Pubitemid 29231100)
22. Koenig W, Sund M, Frohlich M, Fischer H-G, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992. Circulation 1999;99:237-42. (Pubitemid 29056365)
23. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11. (Pubitemid 38823477)
24. Mugabo Y, Li L, Renier G. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev 2010;6:27-34.
25. Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008;52:40-51. (Pubitemid 350235704)
26. Vogel CFA, Sciullo E, Wong P, Kuzmicky P, Kado N, Matsumura F. Induction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates. Environ Health Perspect 2005;113:1536-41. (Pubitemid 41614908)
27. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue LF, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421. (Pubitemid 30349107)
28. Heikkilä K, Ebrahim S, Rumley A, Lowe G, Lawlor DA. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 2007;16:1155-9. (Pubitemid 46984952)
29. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011;12:204-12.
30. Bankier B, Barajas J, Martinez-Rumayor A, Januzzi JL. Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. Eur Heart J 2008;29:2212-7.
31. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57.
32. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-86.
33. Rief W, Hennings A, Riemer S, Euteneuer F. Psychobiological differences between depression and somatization. J Psychosom Res 2010;68:495-502.
34. Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress 2009;12:1-21.
35. Kiecolt-Glaser JK, McGuire L, Robles TF, Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol 2002;70:537-47. (Pubitemid 34640730)
36. Steiner M. Serotonin, depression, and cardiovascular disease: sex-specific issues. Acta Physiologica 2011;203:253-8.
37. Guimaraes S, Moura D. Vascular Adrenoceptors: An Update. Pharmacol Rev 2001;53:319-56. (Pubitemid 32476119)
38. Bishopric NH, Cohen HJ, Lefkowitz RJ. Beta adrenergic receptors in lymphocyte subpopulations. J Allergy Clin Immunol 1980;65:29-33. (Pubitemid 10211117)
39. Brodde OE. Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am Heart J 1990;120:1565-72.
40. Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Trends Immunol 1988;9:230-5.
41. Nieto JL, Laviada ID, Guillen A, Haro A. Adenylyl cyclase system is affected differently by endurance physical training in heart and adipose tissue. Biochem Pharmacol 1996;51:1321-9. (Pubitemid 26142857)
42. Sanders VM. The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv Neuroimmunol 1995;5:283-98.
43. Grisanti LA, Evanson J, Marchus E, Jorissen H, Woster AP, DeKrey W, Sauter ER, Combs CK, Porter JE. Pro-inflammatory responses in human monocytes are [beta]1-adrenergic receptor subtype dependent. Mol Immunol 2005;47:1244-54.
44. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, Fleshner M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005;135:1295-307. (Pubitemid 41416690)
45. Murray DR, Prabhu SD, Chandrasekar B. Chronic {beta}-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000;101:2338-41. (Pubitemid 30329120)
46. Yabuuchi K, Maruta E, Yamamoto J, Nishiyori A, Takami S, Minami M, Satoh M. Intracerebroventricular injection of isoproterenol produces its analgesic effect through interleukin-1[beta] production. Eur J Pharmacol 1997;334:133-40. (Pubitemid 27451981)
47. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002;112:269-74. (Pubitemid 34219439)
48. Anzai T, Yoshikawa T, Takahashi T, Maekawa Y, Okabe T, Asakura Y, Satoh T, Mitamura H, Ogawa S. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. Cardiology 2003;99:47-53. (Pubitemid 36206635)
49. Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, Rana BK, Kennedy BP, Khandrika S, Huang P, Lillie EO, Shih P-AB, Smith DW, Wen G, Hamilton BA, Ziegler MG, Witztum JL, Schork NJ, Schmid-Schönbein GW, O'Connor DT. C-reactive protein, an 'intermediate phenotype'for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/[beta]-adrenergic pathway loci. J Hypertens 2007;25:329-43. (Pubitemid 46071931)
50. Van Tits LJ, Michel MC, Grosse-Wilde H, Happel M, Eigler FW, Soliman A, Brodde OE. Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process. Am J Physiol 1990;258:191-202.
51. Tohmeh JF, Cryer PE. Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest 1980;65:836-40. (Pubitemid 10144057)
52. Cleaveland CR, Rangno RE, Shand DG. A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol. Arch Intern Med 1972;130:47-52.
53. Brodde OE, Kretsch R, Ikezono K, Zerkowski HR, Reidemeister JC. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science 1986;231:1584-5. (Pubitemid 16050732)
54. Christou DD, Seals DR. Decreased maximal heart rate with aging is related to reduced {beta}-adrenergic responsiveness but is largely explained by a reduction in intrinsic heart rate. J Appl Physiol 2008;105:24-9.
55. Jain S, Dimsdale JE, Roesch SC, Mills PJ. Ethnicity, social class and hostility: effects on in vivo [beta]-adrenergic receptor responsiveness. Biol Psychol 2004;65:89-100. (Pubitemid 38050145)
56. Sherwood A, Hughes JW, Kuhn C, Hinderliter AL. Hostility is related to blunted {beta}-adrenergic receptor responsiveness among middle-aged women. Psychosom Med 2004;66:507-13. (Pubitemid 38971244)
57. Yu B-H, Kang E-H, Ziegler MG, Mills PJ, Dimsdale JE. Mood states, sympathetic activity, and in vivo A-adrenergic receptor function in a normal population. Depress Anxiety 2008;25:559-64.
58. Le Melledo J-M, Arthur H, Dalton J, Woo C, Lipton N, Bellavance F, Koszycki D, Boulenger J-P, Bradwejn J. The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4. J Psychosom Res 2001;51:513-20. (Pubitemid 32904181)
59. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25. (Pubitemid 32222454)
60. Godin G, Shephard RJ. Godin Leisure-Time Exercise Questionnaire. Med Sci Sports Exerc 1997;29:36-8.
61. Bao X, Mills PJ, Rana BK, Dimsdale JE, Schork NJ, Smith DW, Rao F, Milic M, O'Connor DT, Ziegler MG. Interactive effects of common beta2-adrenoceptor haplotypes and age on susceptibility to hypertension and receptor function. Hypertension 2005;46:301-7. (Pubitemid 41099161)
62. Ebstein RP, Stessman J, Eliakim R, Menczel J. The effect of age on beta-adrenergic function in man: a review. 1985. Isr J Med Sci 1985;21:302-11. (Pubitemid 15055851)
63. Gameiro C, Romao F. Changes in the immune system during menopause and aging. Front Biosci 2010;2:1299-303.
64. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev 2010;10:319-29.
65. Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 2009;48:111-36.
66. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005;98:1154-62.
67. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010;34:J258-65.
68. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12. (Pubitemid 38057722)
69. Schafer JL. NORM: Multiple Imputation of Incomplete Multivariate Data under a Normal Model [computer software]. University Park, PA: Department of Statistics, The Pennsylvania State University; 1999.
70. Enders CK. A primer on the use of modern missing-data methods in psychosomatic medicine research. Psychosom Med 2006;68:427-36. (Pubitemid 44297675)
71. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol 2009;60:549-76.
72. Allison PD, Hauser RM. Reducing bias in estimates of linear models by remeasurement of a random subsample. Sociol Method Res 1991;19:466.
73. Rubin DB. Multiple imputation after 18+ years. J Am Stat Assoc 1996;91:473-89.
74. Schafer JL. Analysis of incomplete multivariate data. London, UK: Chapman & Hall; 1997.
75. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley & Sons; 1987.
76. Fisher RA. Statistical Methods for Research Workers. Edinburgh, Scotland: Oliver & Boyd Ltd; 1941.
77. Marshall A, Altman D, Holder R, Royston P. Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 2009;9:57.
78. Darmawan IN. Norm software review: handling missing values with multiple imputation methods. Eval J Australasia 2002;2:51-7.
79. O'Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, Carter DC. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol Endocrinol Metab 1995;269:323-30.
80. Hu A, Jiao X, Gao E, Koch WJ, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J Pharmacol Exp Ther 2006;318:469-75. (Pubitemid 44061219)
81. Hu A, Jiao X, Gao E, Li Y, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ. Tonic beta-adrenergic drive provokes proinflammatory and proapoptotic changes in aging mouse heart. Rejuvenation Res 2008;11:215-26. (Pubitemid 351271637)
82. Palmas W, Ma S, Psaty B, Goff DC, Darwin C, Barr RG. Antihypertensive medications and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis. Am J Hypertens 2007;20:233-41. (Pubitemid 46283352)
83. Bastard JP, Jardel C, Delattre J, Hainque B, Bruckert E, Oberlin F. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 1999;99:2219-22.
84. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-3. (Pubitemid 46525079)
85. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-9.
86. Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004;350:2549-57. (Pubitemid 38758542)
87. Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, Capeau J, Bastard JP. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF[alpha], leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004;28:993-7. (Pubitemid 38998704)
88. Warren RS, Starnes HF Jr, Gabrilove JL, Oettgen HF, Brennan MF. The acute metabolic effects of tumor necrosis factor administration in humans. Arch Surg 1987;122:1396-400. (Pubitemid 18058287)
89. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8. (Pubitemid 29177345)
90. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001;47:444-50. (Pubitemid 32222458)
91. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43. (Pubitemid 30165206)
92. Bataille R, Klein B. Serum levels of beta 2 microglobulin and interleukin-6 to differentiate monoclonal gammopathy of undetermined significance. Blood 1992;80:2433-4.
93. Emile C, Fermand J-P, Danon F. Interleukin-6 serum levels in patients with multiple myeloma. Br J Haematol 1994;86:439-40. (Pubitemid 24199027)
94. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-36. (Pubitemid 20053863)
95. Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 2006;36:163-9.
96. Ortega E, Garcia JJ, Bote ME, Martin-Cordero L, Escalante Y, Saavedra JM, Northoff H, Giraldo E. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev 2009;15:42-65.
97. Stewart JC, Janicki-Deverts D, Muldoon MF, Kamarck TW. Depressive symptoms moderate the influence of hostility on serum interleukin-6 and C-reactive protein. Psychosom Med 2008;70:197-204. (Pubitemid 351252968)
98. O'Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin M-T, O'Farrelly C, Malone KM. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun 2010;24:1074-7.
99. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, Ferstl R, von Eynatten M, Wendt T, Rudofsky G, Joswig M, Morcos M, Schwaninger M, McEwen B, Kirschbaum C, Nawroth PP. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003;100:1920-5. (Pubitemid 36254549)
100. Cole SW, Arevalo JMG, Takahashi R, Sloan EK, Lutgendorf SK, Sood AK, Sheridan JF, Seeman TE. Computational identification of genesocial environment interaction at the human IL-6 locus. Proc Natl Acad Sci U S A 2010;107:5681-6.
101. Hanke M, Bailey M, Powell N, Stiner L, Sheridan J. Beta-2 adrenergic blockade decreases the immunomodulatory effects of social disruption stress (SDR). Brain Behav Immun 2008;22:39-40.